|
2024-11-12 |
2024-11-08 |
GV
Geplanter Verkauf
|
Conner Edward R.
Chief Medical Officer
Führungsperson
|
2.117
-100.0%
15,00
31.755 USD
|
2.117
-100.0%
|
15,00
|
31.755 USD
|
|
|
2024-10-31 |
2024-10-29 |
V
Verkauf
|
BVF PARTNERS L P/IL
|
64.617
-26.8%
14,30
924.023 USD
|
64.617
-26.8%
|
14,30
|
924.023 USD
|
|
|
2024-10-31 |
2024-10-29 |
V
Verkauf
|
BVF PARTNERS L P/IL
|
396.963
-22.5%
14,30
5.676.571 USD
|
396.963
-22.5%
|
14,30
|
5.676.571 USD
|
|
|
2024-10-31 |
2024-10-29 |
V
Verkauf
|
BVF PARTNERS L P/IL
|
538.420
-23.1%
14,30
7.699.406 USD
|
538.420
-23.1%
|
14,30
|
7.699.406 USD
|
|
|
2024-10-30 |
2024-10-28 |
GV
Geplanter Verkauf
|
Conner Edward R.
Chief Medical Officer
Führungsperson
|
2.673
-100.0%
15,00
40.095 USD
|
2.673
-100.0%
|
15,00
|
40.095 USD
|
|
|
2024-09-20 |
2024-09-19 |
GV
Geplanter Verkauf
|
Person Julie
CHIEF ADMINISTRATIVE OFFICER
Führungsperson
|
9.497
-100.0%
14,29
135.685 USD
|
9.497
-100.0%
|
14,29
|
135.685 USD
|
|
|
2024-09-20 |
2024-09-19 |
GV
Geplanter Verkauf
|
Conner Edward R.
Chief Medical Officer
Führungsperson
|
4.790
-100.0%
15,00
71.850 USD
|
4.790
-100.0%
|
15,00
|
71.850 USD
|
|
|
2024-09-20 |
2024-09-18 |
GV
Geplanter Verkauf
|
Person Julie
CHIEF ADMINISTRATIVE OFFICER
Führungsperson
|
503
-100.0%
14,00
7.042 USD
|
503
-100.0%
|
14,00
|
7.042 USD
|
|
|
2024-06-28 |
2024-06-26 |
GV
Geplanter Verkauf
|
Person Julie
CHIEF ADMINISTRATIVE OFFICER
Führungsperson
|
10.000
-100.0%
12,46
124.569 USD
|
10.000
-100.0%
|
12,46
|
124.569 USD
|
|
|
2024-06-10 |
2024-06-07 |
V
Verkauf
|
Dittman Jennifer
Chief Development Oper Officer
Führungsperson
|
494
-100.0%
14,17
7.000 USD
|
494
-100.0%
|
14,17
|
7.000 USD
|
|
|
2024-05-22 |
2024-05-20 |
V
Verkauf
|
Dittman Jennifer
Chief Development Oper Officer
Führungsperson
|
1.042
-100.0%
14,00
14.588 USD
|
1.042
-100.0%
|
14,00
|
14.588 USD
|
|
|
2024-05-22 |
2024-05-20 |
V
Verkauf
|
Dittman Jennifer
Chief Development Oper Officer
Führungsperson
|
1.042
-100.0%
14,00
14.588 USD
|
1.042
-100.0%
|
14,00
|
14.588 USD
|
|
|
2024-05-20 |
2024-05-16 |
GV
Geplanter Verkauf
|
Dittman Jennifer
Chief Development Oper Officer
Führungsperson
|
23.578
-100.0%
14,04
331.066 USD
|
23.578
-100.0%
|
14,04
|
331.066 USD
|
|
|
2024-05-10 |
2024-05-09 |
GV
Geplanter Verkauf
|
Holles Natalie C.
CEO
Geschäftsführender Verwaltungsratsmitglied
|
20.222
-1.6%
12,18
246.300 USD
|
20.222
-1.6%
|
12,18
|
246.300 USD
|
|
|
2024-05-10 |
2024-05-09 |
GV
Geplanter Verkauf
|
Holles Natalie C.
CEO
Geschäftsführender Verwaltungsratsmitglied
|
20.222
-1.6%
12,18
246.300 USD
|
20.222
-1.6%
|
12,18
|
246.300 USD
|
|
|
2024-04-15 |
2024-04-11 |
GV
Geplanter Verkauf
|
Holles Natalie C.
CEO
Geschäftsführender Verwaltungsratsmitglied
|
13.558
-1.1%
12,19
165.214 USD
|
13.558
-1.1%
|
12,19
|
165.214 USD
|
|
|
2024-04-08 |
2024-04-04 |
GV
Geplanter Verkauf
|
Person Julie
CHIEF ADMINISTRATIVE OFFICER
Führungsperson
|
1.107
-100.0%
10,00
11.070 USD
|
1.107
-100.0%
|
10,00
|
11.070 USD
|
|
|
2023-12-07 |
2023-12-05 |
GV
Geplanter Verkauf
|
Conner Edward R.
Chief Medical Officer
Führungsperson
|
4.790
-100.0%
10,03
48.062 USD
|
4.790
-100.0%
|
10,03
|
48.062 USD
|
|
|
2023-12-07 |
2023-12-05 |
GV
Geplanter Verkauf
|
Person Julie
Chief Administrative Officer
Führungsperson
|
12.863
-100.0%
10,30
132.484 USD
|
12.863
-100.0%
|
10,30
|
132.484 USD
|
|
|
2022-12-22 |
2022-12-20 |
K
Kauf
|
BVF PARTNERS L P/IL
Large shareholder
|
9.597
+4.1%
4,11
39.430 USD
|
9.597
+4.1%
|
4,11
|
39.430 USD
|
|
|
2022-12-22 |
2022-12-20 |
K
Kauf
|
BVF PARTNERS L P/IL
Large shareholder
|
87.831
+5.2%
4,11
360.862 USD
|
87.831
+5.2%
|
4,11
|
360.862 USD
|
|
|
2022-12-22 |
2022-12-20 |
K
Kauf
|
BVF PARTNERS L P/IL
Large shareholder
|
116.635
+5.3%
4,11
479.207 USD
|
116.635
+5.3%
|
4,11
|
479.207 USD
|
|
|
2022-09-21 |
2022-09-19 |
K
Kauf
|
ORBIMED ADVISORS LLC
Nicht geschäftsführender Verwaltungsratsmitglied
Large shareholder
|
300.000
+5.5%
17,00
5.100.000 USD
|
300.000
+5.5%
|
17,00
|
5.100.000 USD
|
|
|
2022-09-21 |
2022-09-19 |
K
Kauf
|
Bonita David P
Nicht geschäftsführender Verwaltungsratsmitglied
Large shareholder
|
300.000
+5.5%
17,00
5.100.000 USD
|
300.000
+5.5%
|
17,00
|
5.100.000 USD
|
|
|
2022-09-19 |
2022-09-19 |
K
Kauf
|
Atlas Venture Fund XI, L.P.
Large shareholder
|
300.000
+3.0%
17,00
5.100.000 USD
|
300.000
+3.0%
|
17,00
|
5.100.000 USD
|
|
